--------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 14, 2007
ORION HEALTHCORP, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware 001-16587 58-1597246
(State or Other (Commission File (I.R.S. Employer
Jurisdiction of Number) Identification
Incorporation) Number)
1805 Old Alabama Road, Suite 350
Roswell, GA 30076
(Address of Principal Executive Offices) (Zip Code)
(678) 832-1800
(Registrant's Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
--------------------------------------------------------------------------------
Item 2.02 Results of Operations and Financial Condition.
On November 14, 2007, Orion HealthCorp, Inc. (the "Company")
issued a press release reporting financial results for the third
quarter and nine months ended September 30, 2007. The press
release is attached as Exhibit 99.1 to this current report.
Item 8.01 Other Information
Our board of directors has set the meeting date for our
previously announced special stockholder's meeting for Thursday,
November 29, 2007, at 8:00 a.m. local time, at 1805 Old Alabama
Road, Roswell, Georgia 30076, or alternatively, at such later
date, time and place to be determined by our management.
Important Additional Information Filed with the SEC:
We have filed a definitive proxy statement on Schedule 14A with
the Securities and Exchange Commission, and the definitive proxy
statement is being mailed to our stockholders of record as of
October 1, 2007. Before making any voting decision, stockholders
are urged to read the definitive proxy statement carefully in
its entirety because it contains important information about the
proposed transaction, including but not limited to the date,
time and place of the special meeting. Our stockholders and
other interested parties will be able to obtain, without charge,
a copy of the Proxy Statement and other relevant documents filed
with the SEC from the SEC's website at http://www.sec.gov.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits - The following exhibits are furnished as part of this current
report:
Exhibit Description
99.1 Copy of press release issued by the Company on November 14, 2007.
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ORION HEALTHCORP, INC.
By: /s/ Stephen H. Murdock
------------------------
Stephen H. Murdock
Chief Financial Officer
Date: November 14, 2007
EXHIBIT INDEX
Exhibit
Number Description of Exhibits
------ -----------------------
99.1 Copy of press release issued by the Company on November 14, 2007.